{
    "nct_id": "NCT03001310",
    "official_title": "An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2/8-hCARp.hCNGB3) for Gene Therapy of Adults and Children With Achromatopsia Owing to Defects in CNGB3",
    "inclusion_criteria": "* Are aged 3 years or older\n* Have achromatopsia confirmed by a retinal specialist (CI or PI)\nHealthy volunteers allowed\nMust have minimum age of 3 Years",
    "exclusion_criteria": "* Are females who are pregnant or breastfeeding\n* Have participated in another research study involving an investigational medicinal therapy for ocular disease within the last 6 months\n* Have any other condition that the CI/PI considers makes them inappropriate for entry into the trial",
    "miscellaneous_criteria": ""
}